Compounds > deamino-arginine-vasopressin

deamino-arginine-vasopressin and Anemia--Hemolytic

deamino-arginine-vasopressin has been researched along with Anemia--Hemolytic* in 2 studies

Other Studies

2 other study(ies) available for deamino-arginine-vasopressin and Anemia--Hemolytic

Article	Year
Desmopressin may be hazardous in thrombotic microangiopathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:1 Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deamino Arginine Vasopressin; Female; Hemolytic-Uremic Syndrome; Hemostatics; Humans; Middle Aged; Myocardial Infarction; Thrombosis	2001
Factor VIII concentrate-responsive thrombocytopenia, hemolytic anemia, and nephropathy. Evidence that factor VIII:von Willebrand factor is involved in its pathogenesis. The American journal of pediatric hematology/oncology, 1986,Winter, Volume: 8, Issue:4 A 4-year-old Japanese girl had a congenital disorder that was characterized by recurrent thrombocytopenia, hemolytic anemia, hematuria, and proteinuria, which were repeatedly improved by the infusion of factor VIII concentrate. She developed the similar symptoms within 1 h after 1-desamino-8-D-arginine vasopressin (DDAVP) administration. Coagulation studies 30 and 60 min after DDAVP infusion showed a disappearance of large factor VIII:von Willebrand factor (VIII:vWF) multimers, which was the same abnormality that was observed at acute episodes. There were no significant changes in the plasma levels of 6-keto-prostaglandin F1 alpha and thromboxane B2 before and after DDAVP infusion. These results provide further support that VIII:vWF is directly involved in the pathogenesis of this congenital disorder. Topics: Anemia, Hemolytic; Child, Preschool; Deamino Arginine Vasopressin; Factor VIII; Female; Humans; Kidney Diseases; Macromolecular Substances; Recurrence; Thrombocytopenia; von Willebrand Factor	1986

Article

Year

Desmopressin may be hazardous in thrombotic microangiopathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:1

Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deamino Arginine Vasopressin; Female; Hemolytic-Uremic Syndrome; Hemostatics; Humans; Middle Aged; Myocardial Infarction; Thrombosis

2001

Factor VIII concentrate-responsive thrombocytopenia, hemolytic anemia, and nephropathy. Evidence that factor VIII:von Willebrand factor is involved in its pathogenesis.

The American journal of pediatric hematology/oncology, 1986,Winter, Volume: 8, Issue:4

A 4-year-old Japanese girl had a congenital disorder that was characterized by recurrent thrombocytopenia, hemolytic anemia, hematuria, and proteinuria, which were repeatedly improved by the infusion of factor VIII concentrate. She developed the similar symptoms within 1 h after 1-desamino-8-D-arginine vasopressin (DDAVP) administration. Coagulation studies 30 and 60 min after DDAVP infusion showed a disappearance of large factor VIII:von Willebrand factor (VIII:vWF) multimers, which was the same abnormality that was observed at acute episodes. There were no significant changes in the plasma levels of 6-keto-prostaglandin F1 alpha and thromboxane B2 before and after DDAVP infusion. These results provide further support that VIII:vWF is directly involved in the pathogenesis of this congenital disorder.

Topics: Anemia, Hemolytic; Child, Preschool; Deamino Arginine Vasopressin; Factor VIII; Female; Humans; Kidney Diseases; Macromolecular Substances; Recurrence; Thrombocytopenia; von Willebrand Factor

1986